New Delhi: Industry body CII on Wednesday urged for comprehensive review for recognition of intangible assets for keeping pace with expansion of the digital economy. It also said that intangible assets have long been the engines for value creation in the world’s developed economies. “As India is transitioning towards a digital economy, the importance of
TRIQ I-IMSIDA IL-GZIRA, MALTA / ACCESS Newswire / February 4, 2025 / Raketech (STO:RAKE) Raketech Group Holding PLC today announces a non-cash intangible assets impairment charge of EUR 48.5 million and a trading update for the fourth quarter of 2024. Revenues in Q4 2024 are expected to amount to EUR 12.3 million (EUR 22.8 million),
The Confederation of Indian Industry (CII) has urged for a sweeping review of how intangible assets are recognized and accounted for as India shifts towards a digital economy. According to CII, these intangible assets play a vital role in value creation under modern business models, particularly in sectors like Software as a Service (SaaS),
The Confederation of Indian Industry (CII) has urged a comprehensive review of the accounting and recognition framework for intangible assets, highlighting the need to align with India’s transition to a digital economy, where intellectual capital is emerging as a critical driver of value creation for entities. Addressing the challenges around recognition of intangible assets will
New Delhi [India], January 22 (ANI): The Confederation of Indian Industry (CII) has called for a comprehensive review of the recognition and accounting of intangible assets as India transitions towards a digital economy. According to CII, intangible assets are crucial for value creation in modern business models, especially in sectors like Software as a Service
Pentixapharm Holding AG BERLIN, Jan. 07, 2025 (GLOBE NEWSWIRE) — Pentixapharm AG, a developer of innovative radiopharmaceuticals, receives 6.77 million Euro for intangible assets formerly developed by Glycotope from undisclosed Asian pharma and biotech companies. The transaction, which will be effective still in 2024, involves rights that had been transferred to Pentixapharm as part of
Marvell Technology Inc. (NASDAQ:MRVL) has experienced significant volatility in the stock market. Over the past three years, its share price has fluctuated widely, ranging from $36 to $89. Recently, it plunged nearly 11.40% following the announcement of first-quarter guidance that fell short of expectations. Despite this recent drop, I believe Marvell remains significantly overvalued. Growing
Stephen Diorio The Challenge of Getting Accountants, Investors, and Managers To Understand and Agree On the Math of Growth It is inherently difficult to predict and forecast future revenue growth. It’s becoming increasingly more difficult as the nature of the digital economy and the commercial models businesses use for generating revenue growth evolve. This is